← Ascendis Pharma A/S
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Goodwill | $3.5m | $3.5m | $3.5m | $3.5m | — | — | — | — | — | — | |
| Additional Financial Items | |||||||||||
| Current Tax Assets Current | $740k | $778k | $849k | $1.5m | — | $893k | $883k | $802k | $1.8m | $1.8m | |
| Issued Capital | $4.4m | $5.0m | $5.7m | $6.4m | $7.2m | $7.6m | $7.7m | $7.7m | $8.1m | $8.3m | |
| Trade And Other Current Payables | $13.1m | $23.8m | — | — | — | — | — | — | — | — | |
| Trade And Other Payables | — | — | — | $27.8m | $21.9m | $59.4m | $101.0m | $94.6m | $96.7m | $91.7m | |
| Total Assets | $190.1m | $211.0m | $319.0m | $676.7m | $979.8m | $1.1b | $1.1b | $825.6m | $1.2b | $1.3b | |
| LIABILITIES AND EQUITY | |||||||||||
| Deferred Tax Liabilities | — | — | — | — | — | — | $0 | $5.8m | $7.3m | $9.6m | |
| Deferred Tax Liability Asset | — | — | — | — | — | — | — | — | — | ($9.6m) | |
| Total Liabilities | $13.5m | $23.8m | $38.9m | $79.6m | $141.1m | $201.3m | $826.4m | $971.3m | $1.3b | $1.5b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.